theophylline has been researched along with raclopride in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Ferre, S; Fredholm, BB; Fuxe, K; Johansson, B; von Euler, G | 1 |
Ferré, S; Fuxe, K; Li, XM; Ogren, SO; Schwarcz, R; Snaprud, P | 1 |
4 other study(ies) available for theophylline and raclopride
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
Topics: Adenosine; Animals; Apomorphine; Benzazepines; Binding, Competitive; Cell Membrane; Corpus Striatum; Dopamine; Dopamine Agents; Kinetics; Male; Phenethylamines; Phenylisopropyladenosine; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Purinergic; Salicylamides; Theophylline | 1991 |
Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.
Topics: Adenosine; Animals; Antihypertensive Agents; Binding, Competitive; Dopamine D2 Receptor Antagonists; Haloperidol; Kinetics; Male; Membranes; Motor Activity; Neostriatum; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Purinergic P1; Salicylamides; Theophylline | 1994 |